About Albireo Pharma Inc.
On March 2, 2023, Albireo was acquired by Ipsen, strengthening Ipsen’s rare disease portfolio with promising therapeutics for pediatric and adult rare liver diseases. Albireo Pharma is a rare disease company focused on the development of novel bile acid modulators to treat pediatric and adult liver ...
Seamless Pro Tip
Use this information to figure out if this company is an ideal customer for you.
( I )
Albireo Pharma Inc. Company Information
Phone Number
(857) 415-xxxx
Corporate Office Address
10 Post Office Square
Boston, 02109
Website
Industry
PharmaceuticalsNumber of Employees
11 - 50 Employees
Company Revenue
$5M - $20M
Company Social Media Profiles
LinkedIn
linkedin.com/company/albireopharma
Is this company information helpful?
Albireo Pharma Inc.'s Tech Stack
Acquia Cloud
Adobe Creative Suite
Adobe SiteCatalyst
Adobe Tag Manager
